News
Zacks.com on MSN58m
Sanofi Q2 Earnings & Sales Miss, 2025 Top-Line View Raised, Stock Down
SNY misses Q2 earnings and sales estimates but lifts 2025 sales outlook on strong Dupixent and vaccine momentum.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback